Platelet glycoprotein Ib alpha variant fusion polypeptides...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S192100, C424S193100, C530S391100, C530S395000, C530S326000, C514S012200

Reexamination Certificate

active

07727535

ABSTRACT:
The present invention provides compositions and methods for treating or preventing vascular-associated disorders.

REFERENCES:
patent: 5225538 (1993-07-01), Capon et al.
patent: 5340727 (1994-08-01), Ruggeri et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5455165 (1995-10-01), Capon et al.
patent: 5514582 (1996-05-01), Capon et al.
patent: 5516964 (1996-05-01), Umansky et al.
patent: 5593959 (1997-01-01), Miller et al.
patent: 5714147 (1998-02-01), Capon et al.
patent: 6136310 (2000-10-01), Hanna et al.
patent: 6177059 (2001-01-01), Matsuda et al.
patent: 6277975 (2001-08-01), Larsen et al.
patent: 2003/0091576 (2003-05-01), Shaw et al.
patent: 0 317 278 (1989-05-01), None
patent: 1 074 564 (2001-02-01), None
patent: WO 98/08949 (1998-03-01), None
patent: WO 99/51642 (1999-10-01), None
patent: WO 02/063003 (2002-08-01), None
Sergei, T.A., et al. 2000 J of Virology 74(11): 5101-5107.
Yuan, S-M., et al. 1998 Proteins: Structure, Function, and Genetics 30: 136-143.
Seffernick, J.L., et al. Melamine Deaminase and Atrazine Chlorohydrolase: 98 Percent Identical but Functionally Different 2001 Journal of Bacteriology 183(8): 2405-2410.
AttwoodScience, 290(5491):471-473 (2000).
Cole, et al.J. Immunol., 159(7):3613-3621 (1997).
Database Biosis Online Accession No. PREV200200250180, abstract (Nov. 16, 2001).
Database Biosis Online Accession No. PREV200200220561, abstract (Nov. 16, 2001).
Database Biosis Online Accession No. PREV200300080165, abstract (Nov. 5, 2002).
Database Biosis Online Accession No. prev200400161655, abstract (Nov. 16, 2003).
Dong, et al.J. Biol. Chem. 275(36): 27663-27670 (2000).
GenBank Accession No. BAB12083 (Aug. 26, 2000).
GenBank Accession No. AB038516 (Aug. 25, 2000).
GenBank Accession No. BAA12911 (Apr. 14, 2000).
GenBank Accession No. AAC53320 (Aug. 17, 1997).
GenBank Accession No. U91967 (Aug. 17, 1997).
Geneseq Online Database Accession No. AAY49933. (Feb. 1, 2000).
Huizinga et al.Science, 297:1176-1179 (2002).
Kenny et al.Blood, 92(1):175-183 (1998).
Lopez, et al.Proc. Natl. Acad. Sci. USA, 84: 5615-5619 (1987).
Marchese et al.J. Biol. Chem., 270(16):9571-9578 (1995).
Metzler et al.Nat. Struct. Biol., 4(7):527-531 (1997).
Miura et al.J. Biol. Chem., 275(11):7539-7546 (2000).
Ngo et al.Computational complexity, protein structure prediction, and the Levinthal paradox, Chapter 14, pp. 433-506, Birkhauser Boston (1994).
Scalia, et al.Circ. Res., 84(1):93-102 (1999).
Skolnick et al.TIBTECH, 18(1):34-39 (2000).
Titanl, et al.Proc. Natl. Acad. Sci. USA, 84: 5610-5614(1987).
International Search Report for PCT/US2004/019057, mailed on Mar. 4, 2005.
Shaw et al., “A recombinant soluble Ig fusion orm of human GPIbα inhibits platelet aggregation and recurrent coronary cyclic flow reduction in a canine model”, Abstract only, in the 43rdAnnual Meeting of the American Society of Hematology, part 1, andBlood, 98(11):704a (2001).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Platelet glycoprotein Ib alpha variant fusion polypeptides... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Platelet glycoprotein Ib alpha variant fusion polypeptides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet glycoprotein Ib alpha variant fusion polypeptides... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4233459

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.